Is Survodutide legal in the US?
Not yet; it is still in trials.
BSome human evidenceIn clinical trialsas of 2026-10-26
Survodutide is not approved by the FDA or any other regulator. It is an investigational drug in phase 3 trials run by Boehringer Ingelheim and Zealand Pharma. 4
No. It is an investigational drug. Boehringer Ingelheim has reported phase 3 results and is expected to file with regulators. But as of October 2026, no country has an approved product. 4
Read the full Survodutide page
More on Survodutide
Citations
- Sanyal 2024, NEJM: A phase 2 randomized trial of survodutide in MASH and fibrosis doi.org
- StatPearls: Glucagon-like peptide-1 receptor agonists ncbi.nlm.nih.gov
- Kaplan 2026, Nature Medicine: survodutide in obesity with MASLD (SYNCHRONIZE-MASLD), phase 3 doi.org
- Boehringer Ingelheim 2026: SYNCHRONIZE-1 phase 3 obesity trial results (press release) boehringer-ingelheim.com
Reference information only, not medical advice. Drawn from the Survodutide article, fact-checked against the cited sources. No dosing anywhere on this site.